Positive lysosomal modulation as a unique strategy to treat age-related protein accumulation diseases

Rejuvenation Research

Volumn 15, Issue 2, 2012, Pages 189-197

  Bahr, Ben A ^a   Wisniewski, Meagan L ^a   Butler, David ^b  

^a UNIVERSITY OF NORTH CAROLINA AT PEMBROKE   (United States)

^b UNIVERSITY OF HARTFORD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOXISTATIN ACID; ALPHA SECRETASE; ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; BAFILOMYCIN A1; BETA SECRETASE; CATHEPSIN; CATHEPSIN B; CHLOROQUINE; DIAZOACETYL 2 AMINOHEXANOIC ACID METHYL ESTER; GLYCOSIDASE INHIBITOR; GLYCYLPHENYLALANYLGLYCINALDEHYDE SEMICARBAZONE; HUNTINGTIN; INSULINASE; ISOFAGOMINE; LEUPEPTIN; M 31850; MEMBRANE METALLOENDOPEPTIDASE; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PEPSTATIN; PHENYLALANYLALANYLDIAZOMETHYL KETONE; PROTEASOME; PROTEINASE INHIBITOR; RAB PROTEIN; SEMICARBAZONE DERIVATIVE; TAU PROTEIN; TUBULIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AGING; ALZHEIMER DISEASE; ARTICLE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; HIPPOCAMPUS; HUMAN; LYSOSOME; NEUROPROTECTION; NONHUMAN; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL;

AGING; ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; ANIMALS; CATHEPSINS; DEMENTIA; DIAZOMETHANE; HUMANS; HUNTINGTON DISEASE; KETONES; LYSOSOMES; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHAGOCYTOSIS; PROTEASE INHIBITORS; PROTEINS; RAB GTP-BINDING PROTEINS; SYNAPSES; TAU PROTEINS;

EID: 84860282240     PISSN: 15491684     EISSN: 15578577     Source Type: Journal    
DOI: 10.1089/rej.2011.1282     Document Type: Article

References (52)

1. Brunk U, Brun A. The effect of aging on lysosomal permeability in nerve cells of the central nervous system. An enzyme histochemical study in rat. Histochemie 1972;30:315-324
2. Kikugawa K, Beppu M, Kato T, Yamaki S, Kasai H. Accumulation of autofluorescent yellow lipofuscin in rat tissues estimated by sodium dodecylsulfate extraction. Mech Ageing Dev 1994;74:135-148
3. Auer I, Schmidt M, Lee V, Curry B, Suzuki K, Shin R, Pentchev P, Carstea E, Trojanowski J. Paired helical filament tau (PHFtau) in Niemann-Pick type C disease is similar to PHFtau in Alzheimer's disease. Acta Neuropathol 1995;90: 547-551
4. Ginsberg S, Galvin J, Lee V, Rorke L, Dickson D, Wolfe J, Jones M, Trojanowski J. Accumulation of intracellular amyloid-b peptide (Ab 1-40) in mucopolysaccharidosis brains. J Neuropathol Exp Neurol 1999;58:815-824
5. Bahr BA, Bendiske J. The neuropathogenic contributions of lysosomal dysfunction. J Neurochem 2002;83:481-489
6. Mawuenyega KG, Sigurdson W, Ovod V, Munsell L, Kasten T, Morris JC, Yarasheski KE, Bateman RJ. Decreased clearance of CNS b-amyloid in Alzheimer's disease. Science 2010; 330:1774
7. Bendiske J, Caba E, Brown QB, Bahr BA. Intracellular deposition, microtubule destabilization, and transport failure: An ''early'' pathogenic cascade leading to synaptic decline. J Neuropathol Exp Neurol 2002;61:640-650
8. Butler D, Brown QB, Chin DJ, Batey L, Karim S, Mutneja MS, Karanian DA, Bahr BA. Cellular responses to protein accumulation involve autophagy and lysosomal enzyme activation. Rejuvenation Res 2005;8:227-237
9. Stokin GB, Lillo C, Falzone TL, Brusch RG, Rockenstein E, Mount SL, Raman R, Davies P, Masliah E, Williams DS, Goldstein LS. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 2005;307:1282-1288
10. Coleman P, Federoff H, Kurlan R. A focus on the synapse for neuroprotection in Alzheimer disease and other dementias. Neurology 2004;63:1155-1162
11. Severson JA, Finch CE. Reduced dopaminergic binding during aging in the rodent striatum. Brain Res 1980;192:147-162
12. Masliah E, Mallory M, Hansen L, DeTeresa R, Terry R. Quantitative synaptic alterations in the human neocortex during normal aging. Neurology 1993;43:192-197
13. Selkoe DJ. Alzheimer's disease is a synaptic failure. Science 2002;298:789-791
14. Lee S, Sato Y, Nixon RA. Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer's-like axonal dystrophy. J Neurosci 2011;31:7817-7830
15. Bahr BA, Hoffman KB, Yang AJ, Hess US, Glabe CG, Lynch G. Amyloid b protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein. J Comp Neurol 1998;397:139-147
16. Takahashi RH. Intraneuronal Alzheimer Ab42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am J Pathol 2002;161:1869-1879
17. Callahan LM, Vaules WA, Coleman PD. Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neurofibrillary tangles. J Neuropathol Exp Neurol 1999;58:275-287
18. Cataldo AM, Barnett JL, Berman SA, Li J, Quarless S, Bursztajn S, Lippa C, Nixon RA. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomallysosomal system. Neuron 1995;14:671-680
19. Cataldo AM, Petanceska S, Terio NB, Peterhoff CM, Durham R, Mercken M, Mehta PD, Buxbaum J, Haroutunian V, Nixon RA. Ab localization in abnormal endosomes: Association with earliest Ab elevations in AD and Down syndrome. Neurobiol Aging 2004;25:1263-1272
20. Mueller-Steiner S, Zhou Y, Arai H, Roberson ED, Sun B, Chen J, Wang X, Yu G, Esposito L, Mucke L, Gan L. Antiamyloidogenic and neuroprotective functions of cathepsin B: Implications for Alzheimer's disease. Neuron 2006;51:703-714
21. Bahr BA. Lysosomal modulatory drugs for a broad strategy against protein accumulation disorders. Curr Alzheimer Res 2009;6:438-445
22. Sleat DE, Sohar I, Pullarkat PS, Lobel P, Pullarkat RK. Specific alterations in levels of mannose 6-phosphorylated glycoproteins in different neuronal ceroid lipofuscinoses. Biochem J 1998;334:547-551
23. Bendiske J, Bahr BA. Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis-an approach for slowing Alzheimer disease? J Neuropathol Exp Neurol 2003;62:451-463
24. Ditaranto K, Tekirian TL, Yang AJ. Lysosomal membrane damage in soluble Ab-mediated cell death in Alzheimer's disease. Neurobiol Dis 2001;8:19-31
25. Sundelöf J, Sundström J, Hansson O, Eriksdotter-Jönhagen M, Giedraitis V, Larsson A, Degerman-Gunnarsson M, Ingelsson M, Minthon L, Blennow K, Kilander L, Basun H, Lannfelt L. Higher cathepsin B levels in plasma in Alzheimer's disease compared to healthy controls. J Alzheimers Dis 2010;22:1223-1230
26. Bahr BA. Long-term hippocampal slices: A model system for investigating synaptic mechanisms and pathologic processes. J Neurosci Res 1995;42:294-305
27. Butler D, Bahr BA. Oxidative stress and lysosomes: CNSrelated consequences and implications for lysosomal enhancement strategies and induction of autophagy. Antioxid Redox Signal 2006;8:185-196
28. Li QX, Maynard C, Cappai R, McLean CA, Cherny RA, Lynch T, Culvenor JG, Trevaskis J, Tanner JE, Bailey KA, Czech C, Bush AI, Beyreuther K, Masters CL. Intracellular accumulation of detergent-soluble amyloidogenic Ab fragment of Alzheimer's disease precursor protein in the hippocampus of aged transgenic mice. J Neurochem 1999;72: 2479-2487
29. Butler D, Hwang J, Estick C, Nishiyama A, Kumar SS, Baveghems C, Young-Oxendine HB, Wisniewski ML, Charalambides A, Bahr BA. Protective effects of positive lysosomal modulation in Alzheimer's disease transgenic mouse models. PLoS One 2011;6:e20501
30. Bahr BA, Abai B, Gall CM, Vanderklish PW, Hoffman KB, Lynch G. Induction of b-amyloid-containing polypeptides in hippocampus: Evidence for a concomitant loss of synaptic proteins and interactions with an excitotoxin. Exp Neurol 1994;129:81-94
31. Fuentealba RA, Liu Q, Zhang J, Kanekiyo T, Hu X, Lee JM, LaDu MJ, Bu G. Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Ab42 uptake and lysosomal trafficking. PLoS One 2010;5:e11884
32. Sutherland JH, Greenbaum LM. Paradoxical effect of leupeptin in vivo on cathepsin B activity. Biochem Biophys Res Commun 1983;110:332-338
33. Salminen A, Gottesman MM. Inhibitor studies indicate that active cathepsin L is probably essential to its own processing in cultured fibroblasts. Biochem J 1990;272:39-44
34. Kominami E, Tsukahara T, Bando Y, Katunuma N. Autodegradation of lysosomal cysteine proteinases. Biochem Biophys Res Commun 1987;144:749-756
35. Tropak MB, Blanchard JE, Withers SG, Brown ED, Mahuran D. High-throughput screening for human lysosomal b-NAcetyl hexosaminidase inhibitors acting as pharmacological chaperones. Chem Biol 2007;14:153-164
36. Tropak MB, Kornhaber GJ, Rigat BA, Maegawa GH, Buttner JD, Blanchard JE, Murphy C, Tuske SJ, Coales SJ, Hamuro Y, Brown ED, Mahuran DJ. Identification of pharmacological chaperones for Gaucher disease and characterization of their effects on b-glucocerebrosidase by hydrogen/deuterium exchange mass spectrometry. Chembiochem 2008;9:2650-2662
37. Yong AP, Bednarski E, Gall CM, Lynch G, Ribak CE. Lysosomal dysfunction results in lamina-specific meganeurite formation but not apoptosis in frontal cortex. Exp Neurol 1999;157:150-160
38. Ryzhikov S, Bahr BA. Gephyrin alterations due to protein accumulation stress are reduced by the lysosomal modulator Z-Phe-Ala-diazomethylketone. J Mol Neurosci 2008;34:131-139
39. Fuchs D, Berges C, Opelz G, Daniel V, Naujokat C. Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells. J Cell Biochem 2008;103:270-283
40. Bahr BA. Dysfunction and activation of the lysosomal system: Implications for and against Alzheimer's disease. In: Welsh EM (ed). Focus on Alzheimer's Disease Research. Nova Science Publishers, Hauppauge, NY, 2003, pp 115- 150
41. Qin ZH, Wang Y, Kegel KB, Kazantsev A, Apostol BL, Thompson LM, Yoder J, Aronin N, DiFiglia M. Autophagy regulates the processing of amino terminal huntingtin fragments. Hum Mol Genet 2003;12:3231-3244
42. Lee HJ, Khoshaghideh F, Patel S, Lee SJ. Clearance of asynuclein oligomeric intermediates via the lysosomal degradation pathway. J Neurosci 2004;24:1888-1896
43. Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, Oroz LG, Scaravilli F, Easton DF, Duden R, O'Kane CJ, Rubinsztein DC. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 2004;36: 585-595
44. Butler D, Nixon RA, Bahr BA. Potential compensatory responses through autophagic/lysosomal pathways in neurodegenerative diseases. Autophagy 2006;2:234-237
45. de Grey AD, Alvarez PJ, Brady RO, Cuervo AM, Jerome WG, McCarty PL, Nixon RA, Rittmann BE, Sparrow JR. Medical bioremediation: Prospects for the application of microbial catabolic diversity to aging and several major agerelated diseases. Ageing Res Rev 2005;4:315-338
46. Bouvier M. When an inhibitor promotes activity. Chem Biol 2007;14:241-242
47. Yang CN, Shiao YJ, Shie FS, Guo BS, Chen PH, Cho CY, Chen YJ, Huang FL, Tsay HJ. Mechanism mediating oligomeric Ab clearance by naïve primary microglia. Neurobiol Dis 2011;42:221-230
48. Wisniewski ML, Hwang J, Bahr BA. Submicromolar Ab42 reduces hippocampal glutamate receptors and presynaptic markers in an aggregation-dependent manner. Biochim Biophys Acta 2011 1812:1664-1674
49. Pivtoraiko VN, Harrington AJ, Mader BJ, Luker AM, Caldwell GA, Caldwell KA, Roth KA, Shacka JJ. Low-dose bafilomycin attenuates neuronal cell death associated with autophagy-lysosome pathway dysfunction. J Neurochem 2010;114:1193-1204
50. Bahr BA, Vicente JS. Age-related phosphorylation and fragmentation events influence the distribution profiles of distinct tau isoforms in mouse brain. J Neuropathol Exp Neurol 1998;57:111-121
51. Butler D, Bendiske J, Michaelis ML, Karanian DA, Bahr BA. Microtubule-stabilizing agent prevents protein accumulation- induced loss of synaptic markers. Eur J Pharmacol 2007;562:20-27
52. Richardson JM, Woychik NA, Ebert DL, Cardelli JA. Inhibition of early but not late proteolytic processing events leads to the missorting and oversecretion of precursor forms of lysosomal enzymes in Dictyostelium discoideum. J Cell Biol 1988;107:2097-2107